Edition:
United Kingdom

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

145.28USD
4:50pm GMT
Change (% chg)

$0.38 (+0.26%)
Prev Close
$144.90
Open
$145.63
Day's High
$146.15
Day's Low
$145.20
Volume
10,608
Avg. Vol
105,606
52-wk High
$146.18
52-wk Low
$101.58

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $5,230.56
Shares Outstanding(Mil.): 47.59
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 29.01 69.32 32.54
EPS (TTM): 3.79 -- --
ROI: 7.94 8.89 13.82
ROE: 20.38 10.00 15.25

Cancer center CEO leaves Merck board after disclosure scandal

NEW YORK The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.

02 Oct 2018

UPDATE 1-Cancer center CEO leaves Merck board after disclosure scandal

NEW YORK, Oct 2 The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.

02 Oct 2018

Earnings vs. Estimates